| Quantity: | |
|---|---|
SJB16
20μg
Description:
Recombinant human interleukin 29 mutates Cys171, which is not involved in the formation of disulfide bonds in the wild-type IL-29 protein, and retains the disulfide bonds as Cys15-Cys112 and Cys49-Cys145.
Source: E. coli.
Molecular Mass: Approximately 20.0kD.
Purity: ≥97%.
Endotoxin Level: <1EU/µg, determined by the LAL method.
Biological Activity:
Measured in a cytopathic effect inhibition assay using L929/EMCV, ED50<20ng/ml.
Formulation:
Sterile lyophilized powder, in PBS containing 5%Trehalose, 0.01% Tween 80, pH7.4.
Reconstitution:
It is recommended to reconstitute the lyophilized rHuIL-29 in 0.2ml sterile water.
Storage:
Lyophilized samples are stable for greater than six months from date of receipt at -20℃ to -70℃.
Avoid repeated freeze-thaw cycles.
For Laboratory Use Only.
Description:
Recombinant human interleukin 29 mutates Cys171, which is not involved in the formation of disulfide bonds in the wild-type IL-29 protein, and retains the disulfide bonds as Cys15-Cys112 and Cys49-Cys145.
Source: E. coli.
Molecular Mass: Approximately 20.0kD.
Purity: ≥97%.
Endotoxin Level: <1EU/µg, determined by the LAL method.
Biological Activity:
Measured in a cytopathic effect inhibition assay using L929/EMCV, ED50<20ng/ml.
Formulation:
Sterile lyophilized powder, in PBS containing 5%Trehalose, 0.01% Tween 80, pH7.4.
Reconstitution:
It is recommended to reconstitute the lyophilized rHuIL-29 in 0.2ml sterile water.
Storage:
Lyophilized samples are stable for greater than six months from date of receipt at -20℃ to -70℃.
Avoid repeated freeze-thaw cycles.
For Laboratory Use Only.
